Cancer vaccine made from your cells or a donor
Part of Cancer, Digestive system, Hormones & metabolism, Kidney & urinary, Lungs & breathing, Skin, Women’s health & pregnancy clinical trials.
This early-phase trial tests a whole-cell cancer vaccine for people with certain metastatic cancers. It aims to help your immune system recognize and fight the cancer, especially when prior chemotherapy hasn’t worked.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 18 or older
- Have metastatic melanoma, breast, ovarian, colorectal, stomach (gastric), lung, or kidney cancer
- Have had at least one chemotherapy treatment that did not work
- Be able to do daily activities fairly well (performance status score 0 or 1)
- Have enough infection-fighting blood cells (neutrophils above 1000 per cubic millimeter)
- Have acceptable liver and kidney blood tests (ALT/AST under 3× normal; creatinine 1.6 or less)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 study tests a personalized vaccine made for you to help your immune system after you’ve had surgery or ablation for certain cancers. It’s mainly done to check safety and see how well the vaccine can work at preventing cancer from coming back.
This trial tests a personalized cancer vaccine made from your own tumor cells. It is for women with advanced ovarian, fallopian tube, or primary peritoneal cancer that has returned after at least one round of platinum chemotherapy.
This study tests a personalized treatment that uses your own immune cells, trained to recognize your tumor, combined with radiation therapy. It is for people with advanced cancer that has not responded to standard treatments, and aims to help the body fight the cancer more effectively.
This trial tests whether a personalized vaccine—made from your own immune cells mixed with your own tumor material—can help prevent colorectal cancer from coming back after curative surgery. It may help your immune system recognize and fight any remaining cancer cells.
This trial tests a personalized vaccine made from your cancer's unique markers. The goal is to train your immune system to fight the cancer, potentially slowing it down when other options have run out.
This trial tests a personalized vaccine made from your own tumor material, aiming to lower the chance cancer returns after surgery. It is for people whose rare cancers have been removed completely and who have no standard treatment available after surgery.
Hear when a new Colorectal cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.